Evolent Health, Inc.EVHNYSE
LOADING
|||
Switch Symbol:
Gross Profit Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-0.61%
↓ 109% below average
Average (39q)
6.97%
Historical baseline
Range
High:64.64%
Low:-43.74%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -0.61% |
| Q2 2025 | -2.04% |
| Q1 2025 | 35.34% |
| Q4 2024 | -6.17% |
| Q3 2024 | -24.48% |
| Q2 2024 | 2.63% |
| Q1 2024 | 2.44% |
| Q4 2023 | -18.33% |
| Q3 2023 | 6.17% |
| Q2 2023 | -0.01% |
| Q1 2023 | 41.11% |
| Q4 2022 | -3.38% |
| Q3 2022 | 22.40% |
| Q2 2022 | -9.16% |
| Q1 2022 | -7.82% |
| Q4 2021 | 41.34% |
| Q3 2021 | 18.82% |
| Q2 2021 | -12.74% |
| Q1 2021 | -39.86% |
| Q4 2020 | 64.64% |
| Q3 2020 | 9.20% |
| Q2 2020 | 16.09% |
| Q1 2020 | -43.74% |
| Q4 2019 | -8.29% |
| Q3 2019 | 5.75% |
| Q2 2019 | 4.06% |
| Q1 2019 | 0.06% |
| Q4 2018 | 5.64% |
| Q3 2018 | 0.91% |
| Q2 2018 | 11.15% |
| Q1 2018 | 40.60% |
| Q4 2017 | 21.57% |
| Q3 2017 | 1.42% |
| Q2 2017 | 0.95% |
| Q1 2017 | 37.62% |
| Q4 2016 | 6.93% |
| Q3 2016 | 10.81% |
| Q2 2016 | 13.65% |
| Q1 2016 | -1.98% |
| Q4 2015 | 36.21% |